4.5 Review

Dysregulation of miR-638 in the progression of cancers

Journal

PATHOLOGY RESEARCH AND PRACTICE
Volume 220, Issue -, Pages -

Publisher

ELSEVIER GMBH
DOI: 10.1016/j.prp.2021.153351

Keywords

Cancer; miR-638; Tumour-promoting; Tumour-suppressing; Biomarker; Therapeutic agent

Categories

Funding

  1. FRGS grant by Ministry of Higher Education, Malaysia [FRGS/1/2018/STG05/UNIM/02/1, FRGS/1/2014/SG05/UNIM/02/1]

Ask authors/readers for more resources

MicroRNA, particularly miR-638, plays a vital role in regulating human cancer development by targeting downstream genes. By targeting the 3'-ends of its targets, miR-638 regulates cellular processes such as proliferation, invasion, metastases, angiogenesis, apoptosis, and inflammation. This review summarizes the current findings on the roles of miR-638 in various human cancers and discusses its potential applications and challenges as a cancer biomarker and therapeutic agent.
MicroRNA (miRNA) is a form of short, single-stranded and non-coding RNA that is important in regulating the post-transcriptional modification of multiple downstream targets. Many miRNAs have been reported to involve in controlling the progression of human diseases, and one of them is miR-638, which play essential roles in regulating the development of human cancer. By targeting the 3?-ends of its targets, miR-638 can regulate cellular processes including proliferation, invasion, metastases, angiogenesis, apoptosis and inflammation. This review was aimed to summarize current findings on the roles of miR-638 in different human cancers based on the results from various in vitro, in vivo and clinical studies. The biogenesis process and tissue expression, followed by the roles of miR-638 in regulating the development of various human cancers by targeting different downstream targets were covered in this review. The potential applications and challenges of employing miR-638 as cancer biomarker and therapeutic agent were also discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available